Free reference — 99+ guides, IR playbooks, wRVU tracking, and more in RadCall Pro. Start 14-day free trial
Interventional Radiology Updated April 2026

Postpartum Hemorrhage Embolization

Transcatheter arterial embolization (UAE/TAE) for postpartum hemorrhage (PPH) — catheter-directed embolization of bilateral uterine arteries to control life-threatening hemorrhage after vaginal delivery or cesarean section, with uterine and fertility preservation.

Key points
  • Definition: Primary PPH = blood loss >500 mL (vaginal) or >1000 mL (C-section) within 24h. Severe PPH (>1500 mL) requiring IR: uterine atony (70–80%), genital tract laceration, retained placenta, or placenta accreta spectrum (PAS).
  • UAE technical success >90% with preserved fertility in 70–80% of patients who subsequently attempt conception. It is NOT primarily a fertility-preservation procedure — it is a lifesaving hemorrhage control procedure that has the benefit of uterine preservation.
  • Bilateral uterine artery embolization is the standard — unilateral embolization has significantly higher rebleeding rates due to collateral supply.
  • Gelfoam (gelatin sponge) is the preferred embolic agent for PPH — temporary, resorbable, allows uterine recovery; permanent agents (coils alone) risk permanent uterine ischemia and should be reserved for specific situations.
  • Placenta accreta spectrum (PAS): In planned cesarean for PAS (percreta, increta), prophylactic balloon catheters in bilateral internal iliac arteries or uterine arteries are placed pre-operatively; UAE performed immediately post-delivery for hemorrhage control.
  • Obstetrics team coordination is essential — IR should be on call 24/7 for obstetric emergencies; know your institution's massive transfusion protocol and PPH response pathway.

Indications

IndicationMechanismNotes
Primary PPH — uterine atony (70–80% of cases)Uterine muscle failure to contractFirst-line after oxytocin/uterotonics/bimanual compression fail; UAE highly effective
PPH — genital tract laceration refractory to surgical repairArterial injuryUAE if surgical access difficult or coagulopathy makes repair high-risk
PPH — retained placenta / placental polypPlacental bed bleedingUAE then manual extraction or surgical removal
Placenta accreta spectrum (accreta, increta, percreta)Abnormal placentationPre-operative balloon placement; UAE at time of delivery; hysterectomy backup
Secondary PPH (>24h–6 weeks postpartum)Subinvolution, pseudoaneurysm, retained productsUAE; may need superselective embolization of uterine artery pseudoaneurysm
Uterine artery pseudoaneurysmPost-traumatic/post-operative vascular injurySuperselective coil embolization ± covered stent

Contraindications

TypeContraindication
AbsoluteUncorrectable coagulopathy that precludes arterial access (correct simultaneously while proceeding) · Allergy to iodinated contrast without ability to premedicate
RelativeHemodynamic instability requiring immediate surgical control (OR takes priority; IR can still be mobilized simultaneously) · Severe atherosclerosis limiting iliac access · Prior extensive pelvic surgery/radiation

Important: Coagulopathy is never a reason to withhold UAE in life-threatening PPH — correct while proceeding.

Relevant Anatomy

The uterine arteries arise from the anterior division of the internal iliac arteries (hypogastric arteries), cross the ureter at the broad ligament ("water under the bridge"), and supply the uterus via a tortuous ascending branch. Understanding collateral supply is critical — bilateral embolization is mandatory because multiple collateral pathways can sustain uterine bleeding after unilateral treatment.

Uterine Artery Anatomy

  • Origin: Anterior division of the internal iliac artery (IIA); arises near the superior vesical artery
  • Course: Courses medially across the broad ligament, crosses the ureter superiorly ("water under the bridge"), then ascends tortuously along the lateral uterine wall
  • "Corkscrew" morphology: Classic tortuous appearance of normal uterine artery on angiography; straightens with pregnancy/postpartum due to hypertrophy — may appear less tortuous on post-partum angiogram
  • Terminal branches: Fundal, tubal, and ovarian branches at the cornua; cervicovaginal branches inferiorly

Collateral Supply — Why Bilateral UAE Is Critical

Collateral SourceOriginSignificance
Ovarian arteriesAorta (L1–L2 level)Most important collateral; anastomose with uterine artery at cornua; if UAE fails, check aortogram for ovarian artery contribution
Contralateral uterine arteryContralateral anterior IIA divisionMidline anastomoses at uterine fundus; unilateral UAE alone leaves this pathway open
Cervicovaginal branchesUterine artery, internal pudendalInferior uterine supply; may sustain bleeding from cervical lacerations
Internal pudendal arteryAnterior IIA divisionContributes to vaginal and cervical bleeding; consider if bilateral UAE fails
Inferior epigastric arteryExternal iliac arteryRelevant after cesarean section — may contribute to anterior abdominal wall or hysterotomy site bleeding; assess selectively in C-section patients with persistent hemorrhage
Broad ligament arteryVariable; uterine or ovarian artery branchesSmall vessels within the broad ligament; may sustain hemorrhage when main uterine supply is controlled; consider in persistent bleeding despite bilateral UAE

Internal Iliac Artery Divisions

  • Anterior division: Uterine artery, superior vesical, inferior vesical, middle rectal, internal pudendal, obturator — all targets of concern for non-target embolization
  • Posterior division: Iliolumbar, lateral sacral, superior gluteal — not typically involved in UAE

If bilateral UAE fails: Perform aortogram to assess for patent ovarian artery collateral supply. Selective catheterization of the ovarian artery (from the aorta at L1–L2) may be required for complete embolization. Internal pudendal arteries should also be assessed for vaginal/cervical bleeding contribution. After cesarean section, also assess the inferior epigastric artery (from the external iliac) — it may contribute to anterior abdominal wall or hysterotomy site hemorrhage. The broad ligament artery should be considered in persistent bleeding when all named uterine supply has been controlled.

Procedure Overview

The following is a high-level summary. Full catheter selection for bilateral uterine artery access, gelfoam preparation technique, balloon catheter placement for PAS, and troubleshooting for difficult anatomy are available in RadCall Pro.

Access and Setup

  1. Access: Unilateral CFA access with crossover for bilateral UAE; 4–5 Fr sheath
  2. Aortogram (optional): Survey aortic bifurcation, iliac arteries, and identify ovarian artery origins if needed
  3. Internal iliac catheterization: Roberts Uterine Catheter (RUC) or Cobra to select contralateral IIA via aortic crossover; repeat for ipsilateral (Waltman loop or second access)
  4. Uterine artery identification: Selective IIA arteriogram in AP and oblique views; uterine artery is tortuous anterior division vessel coursing medially; identify corkscrew morphology
  5. Superselective uterine artery catheterization: Coaxial microcatheter (2.4–2.8 Fr) into uterine artery; arteriogram to confirm territory and exclude non-target supply

Embolization

  1. Embolization: Gelfoam pledgets (1–2 mm) or slurry as primary embolic. Inject slowly until near-stasis. Do not use permanent agents unless specific indication (pseudoaneurysm = coils). Polyvinyl alcohol particles (PVA) 355–500 µm alternative if gelfoam not available.
  2. Endpoint: Near-complete stasis of uterine artery flow with preserved arterial trunk (avoid over-embolization of proximal trunk — maintains future fertility)
  3. Bilateral: Repeat entire process on contralateral side. Both sides must be treated.
  4. Check for collateral supply: If bleeding continues post bilateral UAE, check for ovarian artery contribution (selective catheterization from aorta) and internal pudendal artery
  5. Post-embolization arteriogram: Confirm bilateral stasis; document

Embolic Agent Selection

AgentCharacteristicsWhen to Use
Gelfoam (gelatin sponge) — pledgets or slurryTemporary (resorbs in 2–6 weeks); non-permanent; allows uterine recoveryPrimary agent for PPH — preserves future fertility; allows uterine revascularization
PVA particles (355–500 µm)Permanent; small particlesAlternative to gelfoam if unavailable; permanent occlusion — less ideal for young patients
Microcoils (0.018" pushable)Permanent; precise placementUterine artery pseudoaneurysm; as adjunct to particles in severe atony; do NOT use as sole agent for atony
N-BCA (cyanoacrylate glue)Liquid embolic; permanent; rapid occlusionRare; refractory cases; requires experience; risk of non-target embolization

Complications

ComplicationRateManagement
Rebleeding requiring repeat UAE or hysterectomy10–15%Repeat embolization if technically feasible; surgical consultation
Post-embolization syndrome (fever, pelvic pain)50–80%Self-limited; NSAIDs, anti-emetics; expected 3–7 days
Uterine necrosis / infection1–2%Requires hysterectomy; rare with gelfoam; higher risk with PVA
Non-target embolization (bladder, bowel)<1%Superselective technique minimizes risk; manage per affected organ
Amenorrhea / ovarian failure1–3%Usually temporary with gelfoam; counsel patients pre-procedure
Access site complications2–5%Standard femoral care; pseudoaneurysm rare
Failed embolization requiring hysterectomy5–10%Have surgical backup; IR and obstetrics coordinate continuously

Post-Procedure Care

  • Monitoring: ICU or high-acuity monitoring post-procedure; serial hemoglobin/hematocrit
  • MTP continuation: Continue massive transfusion protocol (MTP) if activated — embolization does not immediately stop bleeding from coagulopathy
  • Uterotonics: Uterotonic agents continue post-procedure (oxytocin infusion)
  • Pain management: Uterine cramp pain — NSAIDs (ketorolac IV), PCA opioids; expected for 24–72h
  • Uterine necrosis surveillance: Monitor for signs of uterine necrosis: fever >72h, escalating pelvic pain, foul discharge → CT pelvis, gynecology consult
  • Fertility counseling: Pregnancy possible after UAE for PPH; conception rate 65–70%; advise 6-month interval before attempting pregnancy; MRI uterus at 3 months to assess recovery

Placenta Accreta Spectrum (PAS)

PAS represents a spectrum of abnormal placentation with increasing depth of myometrial invasion and significantly elevated hemorrhage risk at delivery. The incidence of PAS is increasing in parallel with the C-section rate.

PAS Spectrum Classification

TypeInvasion DepthFrequency
AccretaSuperficial myometrial invasion (no decidua)~75% of PAS
IncretaDeep myometrial invasion~18% of PAS
PercretaThrough serosa ± adjacent organ invasion (bladder, bowel)~7% of PAS; highest hemorrhage risk

Pre-operative Planning for PAS

  • MRI for depth of invasion assessment: Determines extent of myometrial and extra-uterine involvement; guides surgical and IR planning
  • Multidisciplinary team: Maternal-fetal medicine (MFM), urology, colorectal surgery, IR, blood bank — all must be coordinated before planned delivery
  • Prophylactic balloon placement: Bilateral internal iliac artery or uterine artery balloons placed in IR suite under fluoroscopy before going to OR; inflation at time of uterine incision/delivery to reduce blood loss; UAE performed through same sheaths after balloon deflation
  • Evidence for prophylactic balloons: Mixed evidence on blood loss reduction; major centers use routinely for percreta given potential for catastrophic hemorrhage
  • FIGO 2019 classification: Provides standardized clinical and histological grading for PAS diagnosis and management algorithm

PAS coordination: For any patient with suspected percreta on imaging, IR should be involved in pre-delivery planning, regardless of whether hemorrhage ultimately occurs. Pre-placed sheaths allow immediate UAE without additional access time in a hemorrhaging patient.

Evidence Summary

  • ACOG/SMFM: UAE recommended as first-line for PPH after failed medical/surgical management; success rate 85–95% for uterine preservation
  • Sentilhes et al (2016, Radiology): Systematic review; UAE technical success 90.7%; clinical success 73.7%; fertility preserved in 72.9% of subsequent pregnancies
  • Two large systematic reviews demonstrate UAE for PPH safe with maintained fertility; complication rates acceptable vs. hysterectomy
  • For PAS: Multidisciplinary management with planned UAE reduces need for emergency hysterectomy; major referral centers report substantially lower hysterectomy rates with structured IR involvement

References

  1. Sentilhes L, et al. Fertility and pregnancy outcomes following pelvic arterial embolization for postpartum haemorrhage: a cohort study and systematic review. Eur Radiol. 2016;26(10):3349–3360.
  2. Soyer P, et al. Uterine artery embolization for postpartum hemorrhage: long-term follow-up clinical and angiographic results. Diagn Interv Imaging. 2015;96(4):361–367.
  3. Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol. 2017;130(4):e168–e186.
  4. Collins SL, et al. FIGO Classification for the clinical diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2019;145(1):20–35.
  5. ACOG Committee Opinion No. 764: Medically Indicated Late-Preterm and Early-Term Deliveries. Obstet Gynecol. 2019;133(2):e151–e155.
  6. Matula V, et al. Fertility after transcatheter uterine artery embolization for postpartum hemorrhage — systematic review and meta-analysis. Am J Obstet Gynecol. 2022;226(2):180–192.
  7. d'Archambeau O, et al. Prophylactic uterine artery embolization in patients with placenta accreta spectrum. J Vasc Interv Radiol. 2023;34(3):405–412.

Full technique in RadCall Pro Complete catheter selection for bilateral uterine artery access, gelfoam preparation and injection technique, balloon catheter placement protocol for placenta accreta spectrum, and troubleshooting for difficult anatomy in RadCall Pro.
Start free trial ›